SCN1A and epilepsy: Finally, we show that the NaV1.1 activator AA43279 and the NaV1.6 inhibiting compound MV1312 reduced the burst movement phenotype and the number of epileptiform events in Scn1Lab knockouts, indicating that selective ion channel subtype inhibition or activation could be beneficial in epilepsy.